FlowOx™ by Otivio – Pulsating Negative Pressure Therapy for home use

Welcome to FlowOx™. The world’s first Pulsating Negative Pressure Therapy for home use.

FlowOx™ is convenient, gentle and easy to use. It works by gently stimulating the blood circulation all the way to the skin – like with our muscles, we need to train even the smallest blood vessels (capillaries) in order for them to function.

IN THE PRESS

First RCT to show improved walking capacity


First multi-centre randomized controlled trial using FlowOx™, published in Journal of Vascular Surgery, shows improved walking capacity for patients with intermittent claudication, also known as “windows shopper’s disease”.

Read more here!

OUR PARTNERS

ABOUT FLOWOX™

Is FlowOx™ for me?

What is FlowOx™?

A revolutionary new technology for the treatment of reduced peripheral micro circulation

How does it work?

FlowOx™ works by exercising the blood vessels from the small arteries to the capillaries in the outer layers of the skin.

Who can benefit from using FlowOx™?

FlowOx™ is recommended for patients of over 18 years who suffer from blood flow deficiencies in the lower limbs such as:

a) Peripheral arterial disease (PAD),
b) Diabetic and non-diabetic arteriopathic foot and leg ulcers,
c) Intermittent claudication and rest pain,
d) Foot and lower leg ulcers of mixed aetiology associated with immobility such as paraplegia following spinal injury.

Can FlowOx™ be integrated into an existing therapy?

FlowOx™ is an additional treatment and can be used in conjunction with standard care (typical wound care and medication).

Without FlowOx™ I would have lost my other leg as well and I am not sure I would have been here today. That is what FlowOx™ has done for me..
Stine, Norway

Listen to Stine’s and Hans Thomas’ stories

Stine’s own story

First FlowOx™ patient, Hans Thomas

OTIVIO

FlowOx™ by Otivio


Otivio AS is a Norwegian medtech company based in Oslo. FlowOx™ is a non-invasive medical device for home treatment addressing insufficient blood flow to the limbs associated with peripheral arterial disease, diabetes and other arterial blood flow deficiencies. FlowOx™ is documented to reduce or eliminate these outcomes which represent a big impact on Quality of Life and health care costs. FlowOx™ is CE marked (CE2460) and available in various countries.

Read more about Otivio


GET IN TOUCH

Contact us to get more information about FlowOx™

Scroll to Top